Eve Biomedical, Inc.

Eve Biomedical is developing solutions to enable genomic and personalized medicine. Although improvements in cost per base and cost for whole human genome have been tremendous, the goal of doing this with appropriate accuracy under $1000 has not yet been achieved. Eve Biomedical is developing a compact DNA sequencing system that will be able to sequence the whole human genome at far lower cost; thus help break the barrier of introducing sequencing in clinical diagnostics and jump start the era of genomic medicine.